Carderock Capital Management Inc. bought a new position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,770 shares of the company's stock, valued at approximately $297,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Geode Capital Management LLC lifted its holdings in Procter & Gamble by 7.0% during the 3rd quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company's stock worth $9,538,327,000 after buying an additional 3,619,466 shares in the last quarter. FMR LLC raised its position in shares of Procter & Gamble by 2.7% during the third quarter. FMR LLC now owns 26,556,319 shares of the company's stock worth $4,599,554,000 after acquiring an additional 689,282 shares during the last quarter. Legal & General Group Plc lifted its stake in shares of Procter & Gamble by 0.6% during the second quarter. Legal & General Group Plc now owns 21,632,054 shares of the company's stock valued at $3,567,556,000 after acquiring an additional 122,190 shares during the period. Franklin Resources Inc. boosted its holdings in Procter & Gamble by 10.2% in the third quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company's stock valued at $3,290,573,000 after acquiring an additional 1,760,214 shares during the last quarter. Finally, Fisher Asset Management LLC increased its position in Procter & Gamble by 4.7% in the third quarter. Fisher Asset Management LLC now owns 18,380,610 shares of the company's stock worth $3,183,522,000 after purchasing an additional 830,476 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on PG. Morgan Stanley upped their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a research report on Monday, October 21st. Barclays reduced their price objective on shares of Procter & Gamble from $163.00 to $155.00 and set an "equal weight" rating on the stock in a research note on Friday. Stifel Nicolaus dropped their target price on shares of Procter & Gamble from $167.00 to $161.00 and set a "hold" rating for the company in a research report on Friday. Evercore ISI raised their price target on Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research report on Monday, October 21st. Finally, JPMorgan Chase & Co. cut their target price on Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating on the stock in a research note on Thursday. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of "Moderate Buy" and a consensus target price of $179.65.
Check Out Our Latest Analysis on Procter & Gamble
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the firm's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at $2,343,110. This trade represents a 12.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the company's stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares in the company, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 75,439 shares of company stock valued at $13,317,460 over the last 90 days. 0.18% of the stock is owned by corporate insiders.
Procter & Gamble Stock Up 0.5 %
PG stock traded up $0.85 during trading hours on Friday, reaching $161.35. 7,218,206 shares of the stock were exchanged, compared to its average volume of 5,628,331. The company has a market cap of $379.98 billion, a price-to-earnings ratio of 27.82, a PEG ratio of 3.41 and a beta of 0.45. The firm's 50-day moving average is $169.19 and its 200-day moving average is $169.42. The Procter & Gamble Company has a 12 month low of $146.28 and a 12 month high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period last year, the company earned $1.83 earnings per share. Procter & Gamble's quarterly revenue was down .6% on a year-over-year basis. On average, equities research analysts expect that The Procter & Gamble Company will post 6.93 earnings per share for the current year.
Procter & Gamble Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be issued a $1.0065 dividend. The ex-dividend date of this dividend is Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.50%. Procter & Gamble's dividend payout ratio (DPR) is presently 69.48%.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report